Natriumnitriet Hope (Sodium Nitrite)

Sodium nitrite is employed as a cyanide antidote in acute poisoning scenarios.

• Cyanide poisoning (acute exposure): converts hemoglobin to methemoglobin, which binds cyanide to form cyanmethemoglobin, facilitating detoxification.
• Smoke inhalation in fires: provides rapid cyanide detoxification when inhaled cyanide from combustion gases threatens patients.
• Nitroprusside therapy overdose: counteracts cyanide released during high‑dose nitroprusside infusion in intensive care.
• Industrial chemical accidents: used in emergency protocols for workers exposed to cyanide salts or gases.

• Sodium nitrite oxidizes the iron in hemoglobin from the ferrous (Fe2+) to the ferric (Fe3+) state, producing methemoglobin. Methemoglobin has a high affinity for cyanide ions, forming cyanmethemoglobin, which sequesters cyanide and prevents it from inhibiting cytochrome c oxidase. The resulting complex is then converted to the less toxic thiocyanate by the enzyme rhodanese, allowing renal excretion and reversal of cyanide toxicity.

Sodium nitrite may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Methemoglobinemia (mild): transient increase in methemoglobin levels causing mild cyanosis.
• Hypotension: dose‑related drop in blood pressure, especially with rapid infusion.
• Nausea and vomiting: gastrointestinal discomfort occurring shortly after administration.

Serious or Rare Side Effects

• Severe methemoglobinemia: high methemoglobin levels leading to hypoxia and requiring emergency treatment.
• Hemolysis: destruction of red blood cells, particularly in susceptible individuals.
• Anaphylactic reaction: rare but potentially life‑threatening allergic response requiring immediate intervention.

When using Sodium nitrite, careful clinical monitoring and adherence to safety guidelines are essential.

• Dose determination: administered only under prescriber direction with continuous monitoring.
• Methemoglobin monitoring: check levels frequently during infusion.
• G6PD deficiency: use with caution due to risk of hemolysis.
• Pregnancy and lactation: evaluate risk–benefit before use.
• Concomitant methemoglobin‑inducing drugs: avoid or adjust therapy.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Sodium nitrite can interact with several medications; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

• Methylene blue: antagonizes nitrite effect, reducing cyanide detoxification.
• Other methemoglobin‑inducing agents (e.g., dapsone, phenazopyridine): may cause excessive methemoglobinemia.
• High‑dose nitric oxide donors: additive hypotensive effect.

Moderate Interactions (Monitor Closely)

• Anticoagulants: increased bleeding risk during invasive procedures.
• Antihypertensive agents: potential additive blood pressure lowering.